FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used for treating neuropathic pain syndrome caused by traumatic injuries of the peripheral nervous system. Method involves using the patient’s neuropathic pain syndrome self-monitoring with recording the average hourly pain score independently assessed using the Numeric rating scale-11. An average daily value of neuropathic pain syndrome is determined, and if the average daily value is more than 5 points, pharmacological preparations are used: gabapentin 900–1,800 mg/day, amitriptyline 25–100 mg/day, pramipexole 0.375–1.5 mg/day in combinations.
EFFECT: invention provides reducing the length of treatment and pain intensity in neuropathic pain syndrome.
1 cl, 1 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH ABUSE HEADACHE | 2013 |
|
RU2547565C1 |
METHOD OF ANALGESIC TREATMENT OF CHRONIC MUSCULOSKELETAL PAIN IN PATIENTS WITH RHEUMATIC DISEASES WITH LESIONS OF THE SOMATOSENSORY NERVOUS SYSTEM AND CENTRAL SENSITIZATION | 2022 |
|
RU2798946C1 |
MILNACIPRAN AS MEDICATION FOR CONTINUOUS TREATMENT OF FIBROMYALGIA SYNDROME | 2006 |
|
RU2437661C2 |
METHOD OF TREATING CHRONIC RECURRENT ORAL ULCERATION | 2015 |
|
RU2602684C1 |
METHOD OF PAIN SYNDROMES REDUCTION CAUSED BY MALIGNANT GROWTHS | 2018 |
|
RU2695350C2 |
METHOD OF TREATING NEUROPATHIC PAIN AND ASSOCIATED WITH IT SYNDROMES | 2005 |
|
RU2433825C2 |
METHOD OF TREATING PAIN AFTER LIMB AMPUTATION | 2023 |
|
RU2823155C1 |
METHOD FOR DETERMINING INDICATIONS FOR GABAPENTIN TREATMENT OF PAIN SYNDROME IN BURNING EYE SYNDROME | 2022 |
|
RU2786958C1 |
METHOD FOR TREATMENT OF CHRONIC PAIN SYNDROMES, FORMED ON BASIS OF POST-TRAUMATIC STRESS DISORDER, COMBINED WITH COMBAT BRAIN INJURY EFFECTS | 2016 |
|
RU2643583C1 |
METHOD OF TREATING CHRONIC PAIN SYNDROME | 2014 |
|
RU2545915C1 |
Authors
Dates
2024-08-21—Published
2024-04-02—Filed